Key Echocardiographic Findings
At six months after laparoscopic sleeve gastrectomy, investigators observed significant improvement in multiple parameters of both left and right ventricular performance, including:
Increased left ventricular ejection fraction (LVEF)
Improved right ventricular systolic myocardial velocity
Improved tricuspid annular plane systolic excursion (TAPSE)
Increased E-wave velocity
Better left ventricular global longitudinal strain (GLS)
Structural cardiac changes were also reported, including reductions in:
Right ventricular diameter
Left ventricular end-diastolic volume
Left ventricular end-systolic volume
Pulmonary artery pressure
Importantly, the proportion of patients demonstrating diastolic dysfunction decreased substantially during follow-up, suggesting early reversal of obesity-associated myocardial impairment.
Obesity is increasingly recognized not only as a metabolic disease but also as a condition associated with:
Cardiac remodeling
Diastolic dysfunction
Pulmonary hypertension
Right ventricular strain
Progressive heart failure risk
This study adds objective imaging evidence suggesting that laparoscopic sleeve gastrectomy may produce measurable cardiopulmonary physiologic improvement within only a few months after surgery.
However, the findings should be interpreted cautiously because:
The cohort size was small
The study was observational
No nonoperative control group was included
Long-term durability of cardiac improvement remains uncertain
Therefore, while the data are encouraging, definitive causal conclusions cannot yet be established.
For bariatric and metabolic laparoscopic surgeons, the study provides clinically useful counseling information when discussing the broader systemic benefits of metabolic surgery with patients who have:
Obesity-related cardiomyopathy
Hypertension
Diastolic dysfunction
Obstructive sleep apnea
Early pulmonary hypertension
Reduced exercise tolerance
The findings also reinforce the evolving concept that bariatric surgery should be viewed not solely as a weight-loss procedure, but as a metabolic and cardiophysiologic intervention capable of influencing multiple organ systems.
At the same time, surgeons should avoid overstating the evidence and continue emphasizing that larger prospective controlled studies are necessary before defining the precise cardiac benefits and mechanisms associated with sleeve gastrectomy.
Source: PubMed Study